Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medical Marijuana Inc MJNA

Healthcare
Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in three divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news... see more

Recent & Breaking News (OTCPK:MJNA)

Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company

Business Wire August 1, 2023

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion

GlobeNewswire March 14, 2023

Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries

GlobeNewswire February 6, 2023

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point

GlobeNewswire January 24, 2023

Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology

GlobeNewswire November 29, 2022

Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results

GlobeNewswire November 22, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets

GlobeNewswire November 1, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia

GlobeNewswire October 20, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment

GlobeNewswire October 12, 2022

Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President

GlobeNewswire October 4, 2022

Medical Marijuana, Inc. Signs Deal With Leading European Manufacturer and Distributor to Expand Channel Access to Products Throughout the Region

GlobeNewswire September 8, 2022

Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results

GlobeNewswire August 18, 2022

Medical Marijuana, Inc. Subsidiary HM Pharma Submits CBD Product Dossier; Receives Sanitary Registration in Brazil

GlobeNewswire August 11, 2022

GRN Holdings Corporation, Inc. (OTC: GRNF) Announces Name Change to Marijuana Inc., New Management and Business Model

GlobeNewswire August 5, 2022

Medical Marijuana, Inc. CEO Provides Insight on Future of U.S. Cannabis Market in Nasdaq News

GlobeNewswire July 26, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Health & Wellness Podcast; Secures Features in Top Brazil Lifestyle Publications

GlobeNewswire July 14, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in June 2022

GlobeNewswire July 12, 2022

Medical Marijuana, Inc. Subsidiary HempMeds® Collaborates With Leading Research Hospital in Argentina to Study the Efficiency of CBD for Adult Epilepsy

GlobeNewswire July 6, 2022

Medical Marijuana, Inc. Subsidiary Kannaway Hosts Regional Conference in South Africa

GlobeNewswire June 30, 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in May 2022

GlobeNewswire June 14, 2022